Hiroko Masmune

As Lassogen's Chief Development Officer, Hiroko brings over 30 years of drug development experience to the team. Hiroko has led a wide range of programs at both large and small companies, including Pfizer, Aires, Neurogen, and Viking Therapeutics. Hiroko's expertise spans drug discovery, preclinical development, formulations development, and IND submissions for numerous drug candidates that are in advanced clinical trials. Hiroko earned a PhD at UCLA with Professor Robert Stevens, and conducted postdoctoral studies at MIT with Professor Barry Sharpless.